141 related articles for article (PubMed ID: 38175440)
1. Effect of changes in lymphocyte subsets at diagnosis in acute myeloid leukemia on prognosis: association with complete remission rates and relapse free survivals.
Park SH; Bae MH; Park CJ; Cho YU; Jang S; Lee JH; Lee KH
J Hematop; 2023 Jun; 16(2):73-84. PubMed ID: 38175440
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
Vidriales MB; Orfao A; López-Berges MC; González M; Hernandez JM; Ciudad J; López A; Moro MJ; Martínez M; San Miguel JF
Ann Hematol; 1993 Nov; 67(5):217-22. PubMed ID: 7694663
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the frequencies of bone marrow lymphocyte subsets in adult acute myeloid leukemia at diagnosis.
Sun K; Wang J; Wang YZ; Shi ZY; Chang Y; Yuan XY; Liu YR; Jiang H; Jiang Q; Huang XJ; Qin YZ
Int J Lab Hematol; 2024 Apr; 46(2):294-302. PubMed ID: 38069563
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathologic significance of lymphocyte subsets in acute myeloid leukemia.
Alcasid M; Ma L; Gotlib JR; Arber DA; Ohgami RS
Int J Lab Hematol; 2017 Apr; 39(2):129-136. PubMed ID: 28133918
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Costimulatory Molecule Tim3 on NK Cells and Its Subsets in Patients with Acute Myeloid Leukemia].
Wu WH; Shao JW; Jiang YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1899-1903. PubMed ID: 33283717
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia.
Park Y; Lim J; Kim S; Song I; Kwon K; Koo S; Kim J
Blood Res; 2018 Sep; 53(3):198-204. PubMed ID: 30310785
[TBL] [Abstract][Full Text] [Related]
8. [Detection and Analysis of T Lymphocyte Subsets and B Lymphocytes in Patients with Acute Leukemia].
Cheng J; Ma HZ; Zhang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):327-330. PubMed ID: 30998133
[TBL] [Abstract][Full Text] [Related]
9. [Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation].
Hu KX; Guo M; Yu CL; Wang DH; Sun QY; Qiao JH; Liu GX; Liu TQ; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1527-31. PubMed ID: 20030940
[TBL] [Abstract][Full Text] [Related]
10. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
11. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
12. [The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia].
Liu L; Chen X; Jin HM; Zhao SS; Zhu Y; Qian SX; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):49-55. PubMed ID: 35123603
[TBL] [Abstract][Full Text] [Related]
13. Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT
Zeng X; Yao D; Liu L; Zhang Y; Lai J; Zhong J; Zha X; Lu Y; Jin Z; Chen S; Li Y; Xu L
Asia Pac J Clin Oncol; 2022 Aug; 18(4):456-464. PubMed ID: 34811925
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of peripheral blood lymphocyte subsets in the long-term disease-free survivors of patients with acute myeloblastic leukemia.
Ohnishi K; Yamanishi H; Naito K; Utsumi M; Yokomaku S; Hirabayashi N; Ohno R
Leukemia; 1998 Jan; 12(1):52-8. PubMed ID: 9436920
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.
Inokuchi K; Iwakiri R; Futaki M; Hanawa H; Tanosaki S; Nomura T; Dan K
Leuk Lymphoma; 1998 May; 29(5-6):553-61. PubMed ID: 9643569
[TBL] [Abstract][Full Text] [Related]
16. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
[TBL] [Abstract][Full Text] [Related]
17. NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.
Martner A; Rydström A; Riise RE; Aurelius J; Brune M; Foà R; Hellstrand K; Thorén FB
Oncotarget; 2015 Dec; 6(40):42569-74. PubMed ID: 26544512
[TBL] [Abstract][Full Text] [Related]
18. Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.
Bar M; Othus M; Park HM; Sandhu V; Chen X; Wood BL; Estey E
Leuk Lymphoma; 2015; 56(11):3109-15. PubMed ID: 25726954
[TBL] [Abstract][Full Text] [Related]
19. Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia.
Guo W; Xing C; Dong A; Lin X; Lin Y; Zhu B; He M; Yao R
Cancer Biol Ther; 2013 Oct; 14(10):916-21. PubMed ID: 24030391
[TBL] [Abstract][Full Text] [Related]
20. [Relationship of the Changes of Peripheral Blood Immuno-Cell Subsets with the Prognosis of B Cell Lymphoma Patients].
Zhen JF; Bao F; Zhu MX; Wang J; An R; Pang M; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1657-1662. PubMed ID: 30501700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
